Compliance with the new General Data Protection Regulation (GDPR), scheduled to become effective 25th May 2018, applies to all organizations that control or process personal data of European Union (EU) residents with or without a physical presence in the EU. As a pharmacovigilance solutions provider, ArisGlobal fully supports compliance with GDPR.
Download this ArisGlobal position paper to understand:
- GDPR and its major components related to enterprises
- Its impact on pharmacovigilance-related activities – applicability, consent, data subject rights, PV data entry into the database, processing of PV data, data transfer to international organizations, data security, and the Data Protection Officer
- ArisGlobal’s approach towards GDPR-related compliance – explained across multiple areas and providing our position for how companies can achieve compliance at the level of product, process and people
ArisGlobal Acquires Amplexor Life Sciences, for an Unmatched Regulatory Platform